Advertisement

Organisation › Details
Resalis Therapeutics S.r.l.
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of multiple pathways underlying obesity and fatty liver disease. The company is applying its profound understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders. *
![]() |
Start | 2021-01-01 established |
![]() |
Industry | RES-010 (Resalis Therapeutics, antisense oligonucleotide targeting miR-22) |
Industry 2 | non-coding RNA | |
![]() |
Person | Toniolo, Alessandro (Resalis Therapeutics 202302 CEO before Pfizer + Novartis) |
Person 2 | Puglisi, Pietro (Claris Ventures 201907 Managing Partner + Co-Founder) | |
![]() |
Region | Torino (Turin) (TO) |
Country | Italy | |
Street | 52 Via Nizza | |
City | 10126 Torino (TO) | |
Address record changed: 2023-03-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases". Torino. | ||
Record changed: 2024-01-07 |
Advertisement

More documents for Resalis Therapeutics S.r.l.
- [1] Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases". Torino....
- [2] Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity". Torino....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top